BMRN vs EGAN · P/E 40, rev $2.85B vs P/E 68, rev $88.4M
Biomarin Pharmaceutical Inc (BMRN) versus eGain Corporation (EGAN) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
eGain Corporation (EGAN) is a software - application company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported EGAN revenue for 2025-06-30 was $88.4M. Net income was $32.3M. Revenue was up 293.7% from 2024-06-30 to 2025-06-30. EGAN currently screens at market cap $189.3M and trailing P/E 68.0.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. EGAN currently screens at market cap $189.3M and trailing P/E 68.0.
Not investment advice. Open the BMRN and EGAN stock pages for the full models.
Not investment advice.